dimanche 18 mars 2007
Hélas, ça ne bouge pas beaucoup dans le monde...
Voilà ce que j'ai "piqué" sur le site américain du National Institute of neurological disorders and stroke
What is Alexander Disease?
Alexander disease is a rare, genetically determined degenerative disorder of the central nervous system. It is one of a group of disorders known as the leukodystrophies, diseases that result from imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers in the brain. Myelin, which lends its color to the "white matter" of the brain, is a complex substance made up of at least ten different chemicals. Each of the leukodystrophies affects one (and only one) of these substances. In Alexander disease, the destruction of white matter in the brain is accompanied by the formation of fibrous protein deposits called Rosenthal fibers. It is caused by mutations in the gene for glial fibrillary acidic protein (GFAP). The majority of cases are sporadic (not inherited), but there are families in which more than one child will have the disorder. Alexander disease primarily affects males and usually begins at about 6 months of age. Symptoms may include mental and physical retardation, dementia, enlargement of the brain and head, spasticity (stiffness of arms and/or legs), and seizures. In addition to the infantile form, juvenile and adult onset forms of the disorder have been reported. These forms occur less frequently and have a longer course of progression.
Is there any treatment?
There is no cure for Alexander disease, nor is there a standard course of treatment. Treatment of Alexander disease is symptomatic and supportive.
What is the prognosis?
The prognosis for individuals with Alexander disease is generally poor. Most children with the infantile form do not survive past the age of 6. Juvenile and adult onset forms of the disorder have a slower, more lengthy course.
What research is being done?
The NINDS supports research on genetic disorders, including leukodystrophies such as Alexander disease. The goals of this research are to find ways to prevent, treat, and, ultimately, cure these disorders.
Last updated February 08, 2007
National Institute of Neurological Disorders and Stroke
Ca donne froid dans le dos. Heureusement, le week-end prochain , nous rencontrons des chercheurs français.
Auront-ils de bonnes nouvelles?
What is Alexander Disease?
Alexander disease is a rare, genetically determined degenerative disorder of the central nervous system. It is one of a group of disorders known as the leukodystrophies, diseases that result from imperfect growth or development of the myelin sheath, the fatty covering that acts as an insulator around nerve fibers in the brain. Myelin, which lends its color to the "white matter" of the brain, is a complex substance made up of at least ten different chemicals. Each of the leukodystrophies affects one (and only one) of these substances. In Alexander disease, the destruction of white matter in the brain is accompanied by the formation of fibrous protein deposits called Rosenthal fibers. It is caused by mutations in the gene for glial fibrillary acidic protein (GFAP). The majority of cases are sporadic (not inherited), but there are families in which more than one child will have the disorder. Alexander disease primarily affects males and usually begins at about 6 months of age. Symptoms may include mental and physical retardation, dementia, enlargement of the brain and head, spasticity (stiffness of arms and/or legs), and seizures. In addition to the infantile form, juvenile and adult onset forms of the disorder have been reported. These forms occur less frequently and have a longer course of progression.
Is there any treatment?
There is no cure for Alexander disease, nor is there a standard course of treatment. Treatment of Alexander disease is symptomatic and supportive.
What is the prognosis?
The prognosis for individuals with Alexander disease is generally poor. Most children with the infantile form do not survive past the age of 6. Juvenile and adult onset forms of the disorder have a slower, more lengthy course.
What research is being done?
The NINDS supports research on genetic disorders, including leukodystrophies such as Alexander disease. The goals of this research are to find ways to prevent, treat, and, ultimately, cure these disorders.
Last updated February 08, 2007
National Institute of Neurological Disorders and Stroke
Ca donne froid dans le dos. Heureusement, le week-end prochain , nous rencontrons des chercheurs français.
Auront-ils de bonnes nouvelles?
